drugset / Trial / NCT03164785

Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

NCT03164785 ↗

Phase 2/3 Completed 202 enrolled Second Xiangya Hospital of Central South University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the therapeutic effect and safety of Jinshuibao Capsule on diabetic kidney disease in T2DM patients.

Timeline

Start
2017-07-24
Primary completion
2020-09-26
Completion
2022-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Jinshuibao Capsule Traditional medicine (herbal / TCM) 1.98 g Oral